Jianmin Cui receives $1.7 million NIH grant to study heart's inner mechanisms

Jianmin Cui, PhD, has received a nearly $1.7 million grant from the National Institutes of Health to study the molecular bases for the function of potassium channels vital for the heart, brain, inner ear and other tissues.

The five-year grant from the National Institute of Neurological Disorders and Stroke will allow Cui, professor of biomedical engineering in the School of Engineering & Applied Science at Washington University in St. Louis, to take a close look at some of the mutations in the potassium ion channels KCNQ1 and KCNE1 and their roles in cardiac disorders, including Long QT syndrome and cardiac arrhythmia.

In the heart, KCNQ1 works with KCNE1, an accessory subunit. When the two are put together, the combination changes the properties of the KCNQ1 channel so dramatically that scientists were once misled to believe that KCNE1 formed an entirely new channel on its own, rather than modifying an existing one. KCNQ1 is so important to the heart's rhythm that there are more than 250 mutations of the channel that have been associated with cardiac arrhythmia.

Specifically, Cui will analyze the mechanisms underlying the properties of these potassium ion channels, which will provide more insight into the diseases associated with the mutations. By better understanding these fundamentals, researchers will be able to develop better treatments that target the channels in the heart without affecting the same channels in the gut, thyroid or brain.

Cui proposes that a novel mechanism for activating KCNQ1 is behind these disorders, which can be fatal. Patients with Long QT syndrome who have mutations in KCNQ1 often experience symptoms of cardiac arrhythmia, such as fainting or sudden death, during exercise. Therefore, this study is significant to better understand long QT syndrome, Cui said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New nasal spray form of bumetanide shows promise for heart failure treatment